← Browse by Condition
Medical Condition
gastroesophageal junction adenocarcinoma
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
NCT06340711 Phase 2
Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT05334069
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT05472857 Phase 1
Recruiting
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Enrollment
30 pts
Location
China
Sponsor
Suzhou Immunofoco Biotechnolog...
NCT06121700 Phase 2
Recruiting
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
Enrollment
55 pts
Location
China
Sponsor
Fudan University
NCT04361708 Phase 1
Recruiting
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Enrollment
54 pts
Location
United States
Sponsor
University of Chicago